(2482 words)
AUTHORS CONTRIBUTIONS
All authors reviewed the manuscript. GA provided supervision,
interpreted the data, and drafted the manuscript. dBF conceived and
designed the study, and interpreted the data. DN conceived and designed
the study, and interpreted the data. NB provided clinical study
supervision and interpreted the data. JLF provided supervision and
reviewed the manuscript. SX provided the statistical analysis.
CONFLICTS OF INTEREST
GA and NB are ALYATEC employees. DN is cofounder and ALYATEC employee.
dBF is medical expert, cofounder, and shareholder of ALYATEC. dBF
reports grants from STALLERGENES GREER, grants from CHIESI, and personal
fees from ALK ABELLO, MUNDIPHARMA,
NOVARTIS, and REGENERON and is a member of the Board at STALLERGENES
GREER, NOVARTIS, ALK ABELLO, MUNDIPHARMA, MEDAPHARMA, BOEHRINGER,
ASTRAZENECA, and CALOR. JLF: none